General Medical

The open-label GeneSight and unblined Genomind studies are at high-risk for researcher bias and should be suspect to extreme caution. We would never allow anti-depressants to be approved with these kinds of studies (although unblinded/no-blindplacebo psychotherapy studies are unreasonably and widely “accepted” as robust data by our profession all the […]

Comment by Douglas Berger Psychiatrist in Japan on: Weighing the ... This article has conflated a discussion about the legal, ethical, and alliance-building aspects of whether a clinician may or may not search up and then share information about a patient. Questions 1,2,3 are limiting because they ask about ethics only. Legal: The internet is a public data base and […]

A Response From Douglas Berger to the Article: “To Google ...